Maxwell Stock

CEO & Founder at Signum Biosciences

Maxwell Stock grew up in his father’s lab where he first became enamored with science and the idea of helping people improve their health using science-based approaches. After more than 20 years of developing topical drugs and cosmetic ingredients in the pharmaceutical and cosmetic industries, Max and his team created Epicutis to bring a new paradigm to skincare through clean and minimalist formulations with highly efficacious ingredients focused on skin health not age.


Org chart


Teams


Offices

This person is not in any offices


Signum Biosciences

2 followers

Signum Biosciences develops small molecule therapeutics derived from its STM platform to modulate signal transduction imbalances.


Employees

11-50

Links